abandon 发表于 2025-3-21 17:41:29

书目名称Cancer Immunology影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0221127<br><br>        <br><br>书目名称Cancer Immunology读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0221127<br><br>        <br><br>

NUL 发表于 2025-3-21 21:40:48

http://reply.papertrans.cn/23/2212/221127/221127_2.png

SEVER 发表于 2025-3-22 03:51:50

Recognition of human tumours: melanoma differentiation antigens,w possibilities for the immunotherapy of malignant melanomas. The first clinical trials have already been started . In this chapter, we will concentrate on the available data concerning the characterisation of melanoma-associated differentiation antigens with focus on their immunogenic and protective properties.

痛恨 发表于 2025-3-22 08:25:06

http://reply.papertrans.cn/23/2212/221127/221127_4.png

CONE 发表于 2025-3-22 12:04:53

http://reply.papertrans.cn/23/2212/221127/221127_5.png

SHOCK 发表于 2025-3-22 13:37:07

http://reply.papertrans.cn/23/2212/221127/221127_6.png

SHOCK 发表于 2025-3-22 17:33:51

http://reply.papertrans.cn/23/2212/221127/221127_7.png

责难 发表于 2025-3-22 22:53:23

http://reply.papertrans.cn/23/2212/221127/221127_8.png

Hyperlipidemia 发表于 2025-3-23 03:06:24

H. Kamesaki,S. Fukuhara,H. Uchino,T. Nosakaolely on malignant cells serves as a carrier molecule for a cytotoxic agent. Thereby, the agent is delivered to tumour cells and causes specific cell killing while sparing normal cells the cytotoxic effects.

舞蹈编排 发表于 2025-3-23 07:31:56

http://reply.papertrans.cn/23/2212/221127/221127_10.png
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: Cancer Immunology; R. Adrian Robins,Robert C. Rees Book 2001 Springer Science+Business Media Dordrecht 2001 Antigen.immunotherapy.melanoma